MyAverix Finance
SHE · Healthcare
Hybio Pharmaceutical (300199)
Drug Manufacturers - Specialty & Generic
Hybio Pharmaceutical (300199) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300199
Hybio Pharmaceutical (300199) — FAQ
What is 300199's P/E ratio?
The price-to-earnings (P/E) ratio for Hybio Pharmaceutical (300199) is 18.00 (data as of 2026-03-25).
Does Hybio Pharmaceutical pay a dividend?
Dividend yield is not available in the current snapshot for Hybio Pharmaceutical (300199). Check the MyAverix Finance app for the latest dividend data.
What sector is Hybio Pharmaceutical in?
Hybio Pharmaceutical (300199) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 300199 listed on?
300199 is listed on SHE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.